Mitem Pharma acquired from Novartis worldwide rights to Desferal, commonly used to lower excessive iron levels induced by ...

Columnist Mary Shaniqua, returning from her post-wedding activities, has learned that stepping back from advocacy obligations ...

The stroke rate among adults and children with sickle cell disease in the U.S. is rising, indicating a need for greater ...

The women's sorority plans to donate $2 million by 2028 to St. Jude Children's Research Hospital, which offers care at no ...

Pfizer withdrew Oxbryta (voxelotor), a conditionally approved oral therapy for SCD, saying its benefits don't outweigh risks.

Supplementing with vitamin D for six months safely improved bone health and functional capacity in children and adolescents with sickle cell disease (SCD), a study ...